08.03.15
France
www.pierrefabre.com
Sales: $1.4 billion
Key Personnel: Pierre-Yves Revol, president of Pierre Fabre Foundation and vice chairman Pierre Fabre S.A. Supervisory Board; Eric Ducournau, chief executive officer, dermo-cosmetics division; Michael Danon, senior vice president, legal, pharmaceutical and public affairs; Thierry Denjean, senior vice president, human resources, ethics & sustainable development; Luc Péligry, senior vice president, finance and operations; Marc Alias, director, corporate communications.
Major Products: Avène, A-Derma, Galénic, Darrow (skin and body care), Ducray, Klorane, Glytone (skin and hair care), René Furterer (hair care), Elancyl (body care), Pierre Fabre Dermatologie (Rx and OTC).
New Products: Avène Hydrating Sun Care Range; Klorane Dry shampoo with oat milk – natural tint; Glytone by Ducray Hair Loss Range, Scaly Scalp Range and Sensitive Scalp Range; René Furterer Absolue Keratine range; Eau Thermale Avène XeraCalm A.D Lipid-Replenishing Cream, Balm and Cleansing Oil.
Comments: Pierre Fabre is the third largest French pharmaceutical group and the second largest dermo-cosmetics laboratory in the world. In 2014, corporate sales approached $2.6 billion, with revenues in dermo-cosmetics accounting for 55% and international sales for 55%.
Founded and with its headquarters still based in the southwest of France, Pierre Fabre currently has branches in 44 countries and distribution agreements in more than 130 countries.
Covering a continuum of healthcare products, from prescription drugs and consumer health care products (family care, oral care, natural health) to dermo-cosmetics, Pierre Fabre Laboratories employ more than 10,000 people worldwide.
In 2014, Pierre Fabre dedicated more than 17% of its drug revenues to R&D.
With brands such as Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Galénic, Naturactive, Elgydium, Eludril or Drill, Pierre Fabre Laboratories is a market leader when it comes to skin, hair and oral care products distributed in the French pharmacy channel. Eau Thermale Avène is marketed worldwide, and is the leading dermo-cosmetics brand sold in Europe, Japan and China.
Through the Pierre Fabre Participations holding company, the Pierre Fabre Foundation, a government-recognized public-interest foundation, owns 86% of Pierre Fabre Laboratories. Remaining shares are owned by company employees and through treasury stock.
The French certification group AFNOR has audited Pierre Fabre Laboratories for its corporate social responsibility (CSR) performance at advanced level (AFAQ 26 000).
www.pierrefabre.com
Sales: $1.4 billion
Key Personnel: Pierre-Yves Revol, president of Pierre Fabre Foundation and vice chairman Pierre Fabre S.A. Supervisory Board; Eric Ducournau, chief executive officer, dermo-cosmetics division; Michael Danon, senior vice president, legal, pharmaceutical and public affairs; Thierry Denjean, senior vice president, human resources, ethics & sustainable development; Luc Péligry, senior vice president, finance and operations; Marc Alias, director, corporate communications.
Major Products: Avène, A-Derma, Galénic, Darrow (skin and body care), Ducray, Klorane, Glytone (skin and hair care), René Furterer (hair care), Elancyl (body care), Pierre Fabre Dermatologie (Rx and OTC).
New Products: Avène Hydrating Sun Care Range; Klorane Dry shampoo with oat milk – natural tint; Glytone by Ducray Hair Loss Range, Scaly Scalp Range and Sensitive Scalp Range; René Furterer Absolue Keratine range; Eau Thermale Avène XeraCalm A.D Lipid-Replenishing Cream, Balm and Cleansing Oil.
Comments: Pierre Fabre is the third largest French pharmaceutical group and the second largest dermo-cosmetics laboratory in the world. In 2014, corporate sales approached $2.6 billion, with revenues in dermo-cosmetics accounting for 55% and international sales for 55%.
Founded and with its headquarters still based in the southwest of France, Pierre Fabre currently has branches in 44 countries and distribution agreements in more than 130 countries.
Covering a continuum of healthcare products, from prescription drugs and consumer health care products (family care, oral care, natural health) to dermo-cosmetics, Pierre Fabre Laboratories employ more than 10,000 people worldwide.
In 2014, Pierre Fabre dedicated more than 17% of its drug revenues to R&D.
With brands such as Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Galénic, Naturactive, Elgydium, Eludril or Drill, Pierre Fabre Laboratories is a market leader when it comes to skin, hair and oral care products distributed in the French pharmacy channel. Eau Thermale Avène is marketed worldwide, and is the leading dermo-cosmetics brand sold in Europe, Japan and China.
Through the Pierre Fabre Participations holding company, the Pierre Fabre Foundation, a government-recognized public-interest foundation, owns 86% of Pierre Fabre Laboratories. Remaining shares are owned by company employees and through treasury stock.
The French certification group AFNOR has audited Pierre Fabre Laboratories for its corporate social responsibility (CSR) performance at advanced level (AFAQ 26 000).
